All products

GLP-3 is a novel triple incretin receptor agonist targeting GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors simultaneously. Research has examined its effects on glucose homeostasis, energy expenditure, lipid metabolism, and body weight regulation in preclinical models. It represents an emerging area of research into multi-receptor metabolic modulation. Supplied as a lyophilized powder, 10 mg per vial. For research purposes only — not for human or veterinary use.

Selank is a synthetic heptapeptide analogue of the endogenous tetrapeptide tuftsin (Thr-Lys-Pro-Arg), developed as a research anxiolytic. Studies have examined its modulation of GABA-A receptor activity, BDNF expression, and cytokine balance. Preclinical research has also explored its potential effects on anxiety, cognitive function, and immune system regulation without sedative side effects. Supplied as a lyophilized powder, 11 mg per vial. For research purposes only — not for human or veterinary use.

Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from the N-terminal ACTH (4–7) sequence. Research has focused on its neuroprotective properties, BDNF and NGF upregulation, and potential effects on cognitive performance and stress resilience in animal models. Studies have also examined its anti-inflammatory actions in the central nervous system. Supplied as a lyophilized powder, 11 mg per vial. For research purposes only — not for human or veterinary use.

SS-31 (Elamipretide / MTP-131) is a mitochondria-targeted tetrapeptide that selectively concentrates in the inner mitochondrial membrane and binds cardiolipin. Research has investigated its ability to stabilize cristae structure, reduce mitochondrial ROS production, and improve ATP synthesis in models of mitochondrial dysfunction, ischemia-reperfusion injury, and aging. Supplied as a lyophilized powder, 50 mg per vial. For research purposes only — not for human or veterinary use.

TB-500 is a synthetic peptide fragment (Ac-LKKTETQ) corresponding to the actin-binding domain of Thymosin Beta-4. Research has extensively studied its role in actin polymerization, cell migration, angiogenesis, and tissue repair in wound healing and injury models. Animal studies have explored its potential to promote recovery in musculoskeletal and cardiac tissue. Supplied as a lyophilized powder, 10 mg per vial. For research purposes only — not for human or veterinary use.

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) with a trans-3-hexenoic acid modification that stabilizes it against dipeptidyl peptidase-4 (DPP-4) degradation. Research has examined its effects on GH and IGF-1 secretion, visceral adipose tissue reduction, and lipid metabolism in animal models. It is studied as a model compound in GHRH research. Supplied as a lyophilized powder, 10 mg per vial. For research purposes only — not for human or veterinary use.

Thymosin Alpha-1 (Tα1) is a 28-amino acid peptide derived from the thymosin fraction 5 of the thymus gland. Research has investigated its immunomodulatory properties, including T-cell maturation and differentiation, dendritic cell activation, and cytokine regulation. Studies have explored its potential in models of immune deficiency, chronic infection, and cancer immunology. Supplied as a lyophilized powder, 10 mg per vial. For research purposes only — not for human or veterinary use.

Wolverine is a proprietary research blend combining BPC-157 (10 mg) and TB-500 (10 mg), two peptides with well-documented roles in tissue repair and regeneration research. BPC-157 has been studied for gastrointestinal and musculoskeletal healing, while TB-500 has been investigated for its role in actin regulation, angiogenesis, and wound repair. This combination vial is designed for researchers studying synergistic healing and recovery mechanisms. Supplied as a lyophilized powder blend per vial. For research purposes only — not for human or veterinary use.